Answers are grounded in this paper and cite their sources.
Background Transforming growth factor-β1 (TGF-β1) signaling has been implicated in neuropsychiatric disorders, but its direct electrophysiological effects on central monoaminergic neurons remain unclear. This study examined whether TGF-β1 modulates serotonergic, dopaminergic, and noradrenergic neuronal activity in vivo. Methods Adult rats received acute TGF-β1 administration, and extracellular single-unit recordings were performed from serotonergic neurons in the dorsal raphe nucleus (DRN), dopaminergic neurons in the ventral tegmental area (VTA), and noradrenergic neurons in the locus coeruleus (LC). Additional experiments assessed the involvement of noradrenergic neurotransmission using fusaric acid-induced noradrenaline depletion and the role of TGF-β receptor type I (TGF-βR1) using the antagonist LY2109761. Results TGF-β1 did not significantly alter the firing activity of DRN serotonergic neurons or VTA dopaminergic neurons. In contrast, TGF-β1 significantly reduced the spontaneous firing activity and burst parameters of LC noradrenergic neurons. Noradrenaline depletion with fusaric acid abolished the inhibitory effect of TGF-β1 on LC neuronal activity. Conversely, pharmacological blockade of TGF-βR1 with LY2109761 increased LC neuronal firing, suggesting that endogenous TGF-β1 signaling exerts a tonic inhibitory influence on the noradrenergic system. Conclusion These findings identify TGF-β1/TGF-βR1 signaling as a selective modulator of central noradrenergic neuronal activity. The noradrenaline-dependent suppression of LC firing may represent a mechanism linking TGF-β1 signaling with monoaminergic circuits involved in stress regulation and affective disorders.
No takes yet. Share an insight, caveat, or question.
Račický et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: